ArriVent BioPharma, Inc.
AVBP · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$178M | −$94.3M | −88.2% |
| Net income | −$166M | −$80.5M | −107% |
Questions
- What was ArriVent's revenue in FY2025?
- $0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Mar 2026.
- Was ArriVent profitable in FY2025?
- No: net income was −$166M and operating income −$178M in FY2025.